FDA To Implement Recommendations From 510(k) Task Force Within Months
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to implement recommendations from an internal 510(k) task force within months, Office of Device Evaluation Director Donna Bea Tillman said in a Sept. 25 memo to staff
You may also be interested in...
Shuren's CDRH Sets Ambitious 2010 Agenda: 510(k), PMA Changes Planned
CDRH launched an ambitious 2010 agenda Jan. 20 that includes changes to the 510(k) and PMA pre-market programs by this fall, harmonized international inspection activities by 2011 and unique device identifiers by 2013
Shuren's CDRH Sets Ambitious 2010 Agenda: 510(k), PMA Changes Planned
CDRH launched an ambitious 2010 agenda Jan. 20 that includes changes to the 510(k) and PMA pre-market programs by this fall, harmonized international inspection activities by 2011 and unique device identifiers by 2013
Tighter FDA Review Squeezing Device VCs
For over three decades, medical device investors have accepted the Food and Drug Administration's crucial role as traffic cop for their start-ups. Yes, the agency could be tough, but a green light opened a lucrative road for device companies. But venture capitalists are increasingly worried that tighter controls on regulation could endanger innovation.